This episode of Pharma Sessions is much like a pharmacy - it has something for everyone. Tune in as we reflect on critical conversations hosted by Jonathan Kaskey, so far in the series. Whether it’s critical pathways into pharma careers, the opioid crisis, and work-life balance in the modern pharmaceutical industry, this recap explores it all. From transitioning into MSL roles to building diverse medical teams, guests share practical strategies for career advancement and cross-functional collaboration, offering valuable insights on medical affairs leadership, risk mitigation in pain management, and creating boundaries while working remotely. Think of this as the playbook for pharmaceutical professionals looking to navigate industry challenges and advance their careers.

In this episode of Pharma Sessions, host Jonathan Kaskey talks with Hetal Patel, VP of Medical Affairs at Celltrion USA, about building a medical affairs function from the ground up while launching multiple drugs. Sounds like a hot pot of pressure, decision-making and sleepless nights, doesn't it? Well, don’t let this intimidate you just yet. From transitioning out of big pharma to scaling systems with limited resources, Hetal shares practical strategies for thriving in high-pressure launch environments and how to do so without burning out.

In this episode of Pharma Sessions, host Jonathan Kaskey interviews Dr. Adam Laitman about his unconventional path to becoming a medical director in the pharmaceutical industry. Dr. Laitman shares insights from his career transition from medical school to industry, highlighting the impact of his background in marketing and editorial work. The discussion covers the various career opportunities within medical affairs, the importance of diverse educational backgrounds, and the potential be...

In this episode of Pharma Sessions, host Jonathan Kaskey discusses career transitions into the pharmaceutical industry, specifically focusing on roles like Medical Science Liaisons (MSLs). The guest, Emet Anceaume is the Director of Field Medical Affairs at Immunovant. Emet is a pharmacist by training. She shares her insights on the importance of transferable skills, the challenges and strategies for breaking into pharma, and the distinction between working for big pharma and small biot...

In this episode of Pharma Sessions, hosted by Jonathan Kaskey, Vince Turner shares his insights on integrating creativity into operational environments. The discussion covers Vince's career journey from financial services to pharma, and his operational strategies at Kite. Emphasis is placed on the importance of creativity in solving challenges, the value of building strong relationships, and empowering team members. And stay to the end for the buttermilk pancakes recipe (courtesy of Mel...

In this episode of Pharma Sessions, host Jonathan Kaskey talks with Paul Howe, COO at Protega Pharmaceuticals, about the current and evolving landscape of prescription opioids, abuse deterrent technologies, and the role of technology in public health. They discuss new strategies to improve outcomes for chronic pain patients while reducing addiction risks. Introduction and startling data on prescription abuse Welcome and guest introduction Paul Howe's breakfast routine&nb...

Bursting the Medical Affairs Bubble: A Conversation on Cross-Functional Collaboration In this episode of Pharma Sessions, host Jonathan Kaskey talks with Dr. Samin Saeed, a pharmaceutical medical affairs leader with 17 years of industry experience currently at GSK. They discuss the need for medical affairs to move beyond speaking only to themselves and to engage more openly with other functions within pharmaceutical organizations. Dr. Saeed advocates for a collaborative approach and shares h...

In this episode of Pharma Sessions, host Jonathan Kaskey sits down with Steve Cirillo-Thompson, a seasoned Chief of Staff in the pharmaceutical industry, to delve deep into the unique and often misunderstood role of a Chief of Staff. Steve shares his unconventional journey into the medical affairs space, transitioning from political science to consulting, and eventually stepping into various Chief of Staff roles at some of the leading pharmaceutical companies like Shire, Takeda, Abbvie and Ki...

In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Jen Mohawk, Senior Director of Medical Affairs at Apogee Therapeutics. They discuss the pressing issue of burnout, its financial implications, and how companies benefit from retaining employees rather than constantly seeking new hires. Jen shares her journey from academia to the biopharma industry, driven by her pursuit of a sustainable work-life balance. They delve into practical strategies for integrat...

Future Proofing Medical Affairs: A Conversation with Stephanie Hunter Banks In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Stephanie Hunter-Banks about the future of the medical science liaison (MSL) role and the evolving healthcare ecosystem. Stephanie shares insights on creating a culture of innovation, leveraging big data and AI, and fostering collaboration within pharma companies. She reflects on her own career journey from pharmacy to leading learning ...

Kaskey's Hierarchy of Needs in Medical Affairs: Steering towards Successful Product Launches This episode of Pharma Sessions delves into the evolving role of Medical Affairs in pharmaceutical launches, emphasizing its transition from a supportive to a strategic partnership position. Stephen Dodge, SVP of Medical Affairs at Madrigal Pharmaceuticals has launched 25 products, and shares insights into the crucial involvement of Medical Affairs in launch strategies. The discussion t...

In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Lars Dreesmann, the President and Site Head for Boehringer Ingelheim Fremont about how regulatory affairs can impact patient care. They explore the challenges and opportunities in the regulatory space, including the impact of technology and AI on regulatory affairs and the potential for collaboration between pharmaceutical companies. Lars shares his transition from academia to the pharmaceutical industry, the thrill ...

This episode is sponsored by Acceleration Point. Pharma Sessions is hosted by Jonathan Kaskey In this episode Jonathan and Scott Thompson, the Co-CEO of Acceleration Point, discuss the impact of Artificial Intelligence (AI) on Medical Affairs. Examples of AI use in Medical Affairs include analytics, content creation, and productivity enhancements. Scott encourages experimentation with secure, customized AI tools to improve output. He outlines a case study where AI imp...

Life is different at a biotech. But is that a good thing? Like so much in life, the answer is, "it depends." On this episode I speak with Orlando Granado-Balaez about his journey from being a nurse to transitioning into medical affairs and ultimately thriving in smaller pharmaceutical companies. He shares his experiences in different roles within medical affairs, including being the first MSL in a company and the challenges and rewards that come with building out a team. Orlan...

The Science of Sleep: Exploring its Role in Performance and Well-being for Medical Affairs In this episode of Pharma Sessions, Jonathan Kaskey is joined by Dr. Alison Kole, a sleep expert, to discuss the importance of sleep and its impact on personal and professional health. They discuss the dangers of insufficient and poor-quality sleep, including poor cognitive and creative function. On the other hand, they stress the benefits of prioritizing good quality sleep for enhanced p...

In this compelling episode of Pharma Sessions, host Jonathan Kaskey engages in an insightful discussion with esteemed guest Jose Borbolla-Escoboza. Delving into the intricacies of global launch excellence, Jose, a seasoned oncologist, shares his wealth of experience in pharmaceuticals, particularly in Mexico, the UK, and the US. Together, they explore the multifaceted process of global launch preparation and the crucial role of global in facilitating tools for local country launches.&n...

In this episode of "Pharma Sessions," host Jonathan Kaskey delves into the crucial topic of why negotiation skills are essential in the field of medical affairs. Joining him, Megan Vignos, Head of Scientific and Value Communications for US Medical at Biogen. Together, they explore the importance of negotiation in medical affairs, and how a scientific mindset can aid in building effectiveness. Megan emphasizes the significance of maintaining a positive relationship with complian...

In this episode of Pharma Sessions, host Jonathan Kaskey interviews Dr. Huma Qamar, Head of Clinical Development and Medical Affairs at Ocugen, Inc. With her extensive background in clinical research and medicine, Dr. Qamar has been a pioneer in merging these two fields. Throughout this episode, she shares her invaluable insights on gene therapy, specifically focusing on inherited retinal diseases. Here are the top five things you'll learn: 1. The importance of patient-centered outcomes re...

Join host Jonathan Kaskey in this thought-provoking episode of Pharma Sessions as he invites special guest Denise Bronner, Director of Clinical Trial Diversity and Inclusion at Janssen, to delve into critical issues facing the pharmaceutical industry. Together, they explore the challenges of data sharing, the underrepresentation of non-white individuals in clinical trials, and the need for more inclusive physician training. Top 5 learnings from the episode: The critical need for data shar...

In this episode, host Jonathan Kaskey invites Patrina Pellet to discuss effective time management strategies for medical professionals. From calendar audits to time blocking, Pellet shares valuable insights on how to optimize your daily schedule, prioritize your tasks and avoid feeling burnt out. Discover the power of color-coding and task tracking to manage your workload efficiently and achieve your goals. Tune in now to master the art of time management and increase you...